1. Home
  2. PLYM vs NUVB Comparison

PLYM vs NUVB Comparison

Compare PLYM & NUVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLYM
  • NUVB
  • Stock Information
  • Founded
  • PLYM 2011
  • NUVB 2018
  • Country
  • PLYM United States
  • NUVB United States
  • Employees
  • PLYM N/A
  • NUVB N/A
  • Industry
  • PLYM Real Estate Investment Trusts
  • NUVB Biotechnology: Pharmaceutical Preparations
  • Sector
  • PLYM Real Estate
  • NUVB Health Care
  • Exchange
  • PLYM Nasdaq
  • NUVB Nasdaq
  • Market Cap
  • PLYM 981.1M
  • NUVB 1.1B
  • IPO Year
  • PLYM 2017
  • NUVB N/A
  • Fundamental
  • Price
  • PLYM $22.14
  • NUVB $3.70
  • Analyst Decision
  • PLYM Hold
  • NUVB Strong Buy
  • Analyst Count
  • PLYM 7
  • NUVB 7
  • Target Price
  • PLYM $20.83
  • NUVB $8.43
  • AVG Volume (30 Days)
  • PLYM 840.2K
  • NUVB 7.2M
  • Earning Date
  • PLYM 11-05-2025
  • NUVB 11-05-2025
  • Dividend Yield
  • PLYM 4.34%
  • NUVB N/A
  • EPS Growth
  • PLYM 439.08
  • NUVB N/A
  • EPS
  • PLYM 2.89
  • NUVB N/A
  • Revenue
  • PLYM $171,801,000.00
  • NUVB $14,355,000.00
  • Revenue This Year
  • PLYM $1.88
  • NUVB $332.80
  • Revenue Next Year
  • PLYM $9.24
  • NUVB $360.12
  • P/E Ratio
  • PLYM $7.66
  • NUVB N/A
  • Revenue Growth
  • PLYM N/A
  • NUVB 900.35
  • 52 Week Low
  • PLYM $12.70
  • NUVB $1.54
  • 52 Week High
  • PLYM $22.65
  • NUVB $4.09
  • Technical
  • Relative Strength Index (RSI)
  • PLYM 64.40
  • NUVB 65.98
  • Support Level
  • PLYM $21.98
  • NUVB $2.99
  • Resistance Level
  • PLYM $22.50
  • NUVB $3.95
  • Average True Range (ATR)
  • PLYM 0.38
  • NUVB 0.24
  • MACD
  • PLYM -0.16
  • NUVB 0.03
  • Stochastic Oscillator
  • PLYM 62.71
  • NUVB 73.96

About PLYM Plymouth Industrial REIT Inc.

Plymouth Industrial REIT Inc is a full-service, vertically integrated, self-administered, and self-managed Maryland corporation. It is focused on the acquisition, ownership, and management of single and multi-tenant Class B industrial properties, including distribution centers, warehouses, and light industrial properties, located in secondary and primary markets across the United States. The company has one reportable segment, which is Industrial properties. The majority of its property portfolio is spread across Florida, Ohio, Indiana, Tennessee, Illinois and Georgia, among others. It receives income from the rental revenue through its properties.

About NUVB Nuvation Bio Inc.

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes differentiated, novel oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in their different stages of development. The company generates revenue through out-licensing collaborative agreements with its customers located in China and Japan.

Share on Social Networks: